Integrative Analysis of <i>PAIP2B</i> to Identify a Novel Biomarker for Pancreatic Ductal Adenocarcinoma

Integrative Analysis of <i>PAIP2B</i> to Identify a Novel Biomarker for Pancreatic Ductal Adenocarcinoma

The aim of the study was to evaluate the potential diagnostic and prognostic value of gene, Poly A-Binding Protein Interacting Protein 2B (PAIP2B) in pancreatic cancer. We used the gene expression data and clinical information of pancreatic adenocarcinoma patients from The Cancer Genome Atlas databa...

Full description

Bibliographic Details
Main Authors:	Yaoxian Xiang, Li Wang, Yurong Cheng, Huanjuan An, Chan Zhang, Jing Wang, Yingying Tong, Dong Yan
Format:	Article
Language:	English
Published:	Georg Thieme Verlag KG 2023-12-01
Series:	Global Medical Genetics
Subjects:	pancreatic carcinoma PAIP2B overall survival prognosis biomarker
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-1777789

Similar Items

PAIP2 is a potential diagnostic and prognostic biomarker of breast cancer and is associated with immune infiltration
by: Chenyu Wang, et al.
Published: (2022-11-01)

Development and Validation of a Nomogram to Predict Survival in Pancreatic Head Ductal Adenocarcinoma After Pancreaticoduodenectomy
by: Feng Peng, et al.
Published: (2021-09-01)

Prognostic Biomarkers for Pancreatic Ductal Adenocarcinoma: An Umbrella Review
by: Yizhi Wang, et al.
Published: (2020-09-01)

The systemic inflammation response index predicts survival and recurrence in patients with resectable pancreatic ductal adenocarcinoma
by: Li S, et al.
Published: (2019-04-01)

Prognostic value of γ‐glutamyltransferase‐to‐albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery
by: Shuo Li, et al.
Published: (2019-02-01)

Role of Immune Microenvironment in Pancreatic Ductal Adenocarcinoma: Could It Be Considered a Predictor of Prognosis?
by: Ottavia De Simoni, et al.
Published: (2023-06-01)

Real-Life Results of Palliative Chemotherapy in Metastatic Pancreatic Ductal Adenocarcinoma
by: Bianca Varzaru, et al.
Published: (2023-07-01)

Impact of Patient Age on Postoperative Short-Term and Long-Term Outcome after Pancreatic Resection of Pancreatic Ductal Adenocarcinoma
by: Danilo Hackner, et al.
Published: (2022-08-01)

Hyperdense Pancreatic Ductal Adenocarcinoma: Clinical Characteristics and Proteomic Landscape
by: He Xu, et al.
Published: (2021-02-01)

Impact of Aspirin Intake on Postoperative Survival after Primary Pancreatic Resection of Pancreatic Ductal Adenocarcinoma—A Single-Center Evaluation
by: Danilo Hackner, et al.
Published: (2023-05-01)

PAIP1 regulates expression of immune and inflammatory response associated genes at transcript level in liver cancer cell
by: Jianfeng Zheng, et al.
Published: (2023-04-01)

Score for the Overall Survival Probability of Patients With Pancreatic Adenocarcinoma of the Body and Tail After Surgery: A Novel Nomogram-Based Risk Assessment
by: Chaobin He, et al.
Published: (2020-04-01)

Identification of Novel Molecular Therapeutic Targets and Their Potential Prognostic Biomarkers Among Kinesin Superfamily of Proteins in Pancreatic Ductal Adenocarcinoma
by: Yang Yang, et al.
Published: (2021-09-01)

Expression Profiles of Cuproptosis-Related Genes Determine Distinct Subtypes of Pancreatic Ductal Adenocarcinoma
by: Yusheng Chen, et al.
Published: (2023-01-01)

Clinical Outcome and Prognostic Factors of Pancreatic Adenosquamous Carcinoma Compared to Ductal Adenocarcinoma—Results from the German Cancer Registry Group
by: Rüdiger Braun, et al.
Published: (2022-08-01)

Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal Adenocarcinoma
by: Wenjing Song, et al.
Published: (2021-06-01)

Overall survival in patients over 40 years old with surgically resected pancreatic carcinoma: a SEER-based nomogram analysis
by: Jian Li, et al.
Published: (2019-07-01)

The differential effects of sarcopenia and cachexia on overall survival for pancreatic ductal adenocarcinoma patients following pancreatectomy: A retrospective study based on a large population
by: Xiao‐ding Shen, et al.
Published: (2023-05-01)

Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival
by: Consuelo Amantini, et al.
Published: (2019-09-01)

Prognostic Analysis and Influencing Serum Biomarkers of Patients With Resectable Pancreatic Adenosquamous Cancer
by: Yusheng Shi, et al.
Published: (2021-01-01)

Prognostic Value of Transfer Learning Based Features in Resectable Pancreatic Ductal Adenocarcinoma
by: Yucheng Zhang, et al.
Published: (2020-10-01)

Tumor Stroma Area and Other Prognostic Factors in Pancreatic Ductal Adenocarcinoma Patients Submitted to Surgery
by: Maria João Amaral, et al.
Published: (2023-02-01)

Stage IA Patients With Pancreatic Ductal Adenocarcinoma Cannot Benefit From Chemotherapy: A Propensity Score Matching Study
by: Yuchao Zhang, et al.
Published: (2020-07-01)

Clinical-radiomics nomogram using contrast-enhanced CT to predict histological grade and survival in pancreatic ductal adenocarcinoma
by: Chunyuan Cen, et al.
Published: (2023-09-01)

CT texture features are associated with overall survival in pancreatic ductal adenocarcinoma – a quantitative analysis
by: Armin Eilaghi, et al.
Published: (2017-06-01)

Survival Benefit of Resection Surgery for Pancreatic Ductal Adenocarcinoma with Liver Metastases: A Propensity Score-Matched SEER Database Analysis
by: Thomas M. Pausch, et al.
Published: (2021-12-01)

Development and Validation of a 7-Gene Prognostic Signature to Improve Survival Prediction in Pancreatic Ductal Adenocarcinoma
by: Zengyu Feng, et al.
Published: (2021-05-01)

Overexpression of OAS1 Is Correlated With Poor Prognosis in Pancreatic Cancer
by: Lingling Lu, et al.
Published: (2022-07-01)

An Automated Prognostic Model for Pancreatic Ductal Adenocarcinoma
by: Ioannis Vezakis, et al.
Published: (2023-08-01)

Development and external validation of a radiomics combined with clinical nomogram for preoperative prediction prognosis of resectable pancreatic ductal adenocarcinoma patients
by: Fangqing Wang, et al.
Published: (2022-11-01)

The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma
by: Ben George, et al.
Published: (2021-10-01)

A nomogram predicting overall survival in patients with non-metastatic pancreatic head adenocarcinoma after surgery: a population-based study
by: Wenbo Zou, et al.
Published: (2021-05-01)

Metastatic pancreatic adenocarcinomas could be classified into M1a and M1b category by the number of metastatic organs
by: Fang Feng, et al.
Published: (2020-08-01)

Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
by: Jannat Pervin, et al.
Published: (2023-10-01)

Preoperative plasma fibrinogen and C-reactive protein/albumin ratio as prognostic biomarkers for pancreatic carcinoma
by: Xiaopeng Chen, et al.
Published: (2024-03-01)

Prognostic Value of Circulating Cell-Free DNA Concentration and Neutrophil-to-Lymphocyte Ratio in Patients with Pancreatic Ductal Adenocarcinoma: A Prospective Cohort Study
by: Bianca Varzaru, et al.
Published: (2024-03-01)

Prior irinotecan exposure does not preclude benefit to liposomal irinotecan in patients with metastatic pancreatic ductal adenocarcinoma
by: Kenneth H. Yu, et al.
Published: (2023-04-01)

Prognostic potential of nutritional risk screening and assessment tools in predicting survival of patients with pancreatic neoplasms: a systematic review
by: Mengxia Yu, et al.
Published: (2024-02-01)

Identification of prognostic splicing factors and exploration of their potential regulatory mechanisms in pancreatic adenocarcinoma
by: Min-hua Rong, et al.
Published: (2020-02-01)

Application of Proteomics in Pancreatic Ductal Adenocarcinoma Biomarker Investigations: A Review
by: Christina Jane Vellan, et al.
Published: (2022-02-01)